News
The combined solution, the NimbleGen CGX array workflow, uses advanced microarray technologies from Roche with the cytogenetic-focused array design and analysis software developed from Signature ...
Optical genome mapping (OGM) detected pathogenic structural variants (SVs) in 20.5% of samples (41/200); combination of chromosomal microarray analysis (CMA) and karyotyping (KT) detected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback